Laserfiche WebLink
Department of Haal A SeMces <br /> State of alifomia—H 1th and Welfare Agency <br /> Page 1 of 7 pis <br /> RADIOACTIVE MATERIAL LICENSE <br /> Pursuant to the California Administrative Code, Title 17, Chapter 5,Subchapter4, Group 2,Licensing of Radioactive Material,and in reliance <br /> on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive,use,possess, <br /> transfer, or dispose of radioactive material listed below,'and to use such radioactive material for the purposes)and at the place(s1 designated <br /> below. This license is subject to all applicable rules,regulations,and orders of the Department of Health Services now or hereafter in effect and <br /> to any conditions specifled in this license. <br /> 1. Licensee 3. License No. <br /> St. Joseph's Medical Center 1276-39 Amendment No. 58 <br /> 2 Address 1800 North California Street 4, Expiration date November 19, 1995 <br /> Stockton, CA 95204 <br /> S. inspection agency Radiologic Health Branch <br /> AMsnrion: Lawrence A. Philipp <br /> Chief Operating Officer Sacramento <br /> in respcnsr to the letter with attachments dated August 16, 1994, signed by <br /> Jack L. Funaaura, M.D., Chairman, Radiation Safety Cvlmtittee, License Number 7276-39 <br /> is hereby amended as follows: <br /> In accordance with California Radiation Control Regulations, Title 17, Subchapter 4, <br /> Article 4, Section 30195, the Medical Use Groups specified below grant the use of <br /> radioactive material, as approved by the U.S. Food and Drug Achninistration, the <br /> California State Board of Medical Quality Assurance and/or the California State <br /> Board of Pharmacy, for diagnosis and treatment of 'patients, when prescribed and as <br /> directed by an appropriately authorized physician listed on this license. <br /> GROUPS AUTHORIZED UNDER THIS LICENSE: <br /> Group 1 - Diagnostic studies involving measurement of uptake, dilution, or excretion <br /> but not involving imaging. <br /> imaging excluding the use of Xenon 127 and/or <br /> Group 2 - Diagnostic studies involving <br /> Xenon 133 gas. <br /> Group 3 - Use of reagents kits for preparation of radiopharmaceuticals listed in <br /> Group 2. <br /> Group 4 - Internal therapy not usually requiring hospitalization. <br /> Group 5 - Internal therapy usually requiring hospitalization for purposes of <br /> radiation safety. <br /> Group 6 - Sealed or solid sources manufactured, labeled, packaged, and distributed <br /> in accordance with a specific license issued pursuant to 10CFR32.74 or a <br /> specific license issued by an agreement state pursuant to equivalent state <br /> regulations (except for sources manufactured prior to August 16, 1974) . <br /> 6. Nuclide 7. Form 9. Authorized Use <br /> A. Cesium 137 A. Sealed Sources A. Treatment of Cancer <br /> B. Iridium 192 B. Seeds in Ribbon B. Treatment of Cancer <br /> C. Palladium 103 C. Seeds C. Treatment of Cancer <br /> For the State Department of Health Services <br /> October 11, 1994 3 <br /> Date by <br /> Radiologic Health Section <br /> 744 P Street,Sacramento,CA 95814 <br /> RH 2550(2/81) <br />